Maharashtra FDA cancels Cipla’s Pune warehouse drug licences
By United One News · AI-generated summary of 2 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
The Maharashtra FDA revoked Cipla Pharma & Life Sciences’ wholesale drug licences at its Pune warehouse for storage, packaging and record‑keeping violations.
- Licences cancelled after FDA found misbranding of a medicine.
- Violations included improper drug storage and inventory management.
- The action followed fresh proceedings ordered by the High Court.
Covered by 2 outlets across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Maharashtra FDA Cancels Cipla Pharma & Life Sciences’ Pune Warehouse Drug Licences Over Multiple Lapses
Timeline
First reported by Free Press Journal on ; 2 articles from 2 outlets so far.
Who is covering this story
- Center (2): Free Press Journal, Mint